Showing 241-250 of 20328 results for "".
State of the Art Treatment of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/state-of-the-art-treatment-of-type-1-diabetes/1105/How has the management of diabetes changed for children in the last 20 years? Join Dr. William Tamborlane with an update on the state of the art treatments for type 1 diabetes.Optimizing Athletic Performance in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/optimizing-athletic-performance-in-type-1-diabetes/6386/Patients living with type 1 diabetes who are involved in athletics present particular challenges to approaching to their management, medication regimen and nutrition. How can healthcare professionals help their type 1 athletes optimize their performance and manage their diabetes? Join host Dr. SteveInvestigating the Link Between Type 2 Diabetes & Obesity
https://reachmd.com/programs/diabetes-discourse/investigating-the-link-between-type-2-diabetes-obesity/12632/Are there differences between type 2 diabetes in males and females, and is this disease linked to obesity?The Benefits of TZDs for Early Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/the-benefits-of-tzds-for-early-type-2-diabetes/5343/Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesisNovel Therapies for Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/novel-therapies-for-type-1-diabetes/1767/How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease phyType 1 Diabetes: Control and Cure
https://reachmd.com/programs/clinicians-roundtable/type-1-diabetes-control-and-cure/1771/Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cType 2 Diabetes in Children and Adolescents
https://reachmd.com/programs/diabetes-discourse/type-2-diabetes-in-children-and-adolescents/5084/The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’sExploring Stem Cell Research & Novel Options in Type 1 Diabetes
https://reachmd.com/programs/diabetes-discourse/exploring-stem-cell-research-and-novel-options-in-diabetes/12273/Is there an alternative to insulin injections for patients with type 1 diabetes?Uncovering the Prevalence of Type 1 Diabetes in Older Adults
https://reachmd.com/programs/diabetes-discourse/uncovering-the-prevalence-of-type-1-diabetes-in-older-adults/17888/Treating older adults with type 1 diabetes requires proactive assessment and management strategies. Here are ways to improve outcomes in a population faced with increased complications.Supporting Patients with Type 1 Diabetes.
https://reachmd.com/programs/clinicians-roundtable/supporting-patients-with-type-1-diabetes/1106/What are the best practices in supporting a patient and their family in treating type 1 diabetes? How do you educate the family, How do you monitor the child? What is the physicians role in the management of a 24/7 disease. In this segment Dr. William Tamborlane shares his vast experience of caring